To further provide a rationale for using HIF-1α inhibitors as an adjunctive medical therapy for small AAAs, we tested whether pharmacological HIF-1α inhibitors could attenuate AngII-induced AAA in vivo. The gene discussed is AGT; the disease is achalasia-alacrima syndrome.